Literature DB >> 31839232

Commentary: Doubling down on adeno-associated viruses for cardiac gene therapy.

Christopher T Ryan1, Ravi K Ghanta2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31839232      PMCID： PMC9413020          DOI： 10.1016/j.jtcvs.2019.10.111

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   6.439


× No keyword cloud information.
  12 in total

1.  Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models.

Authors:  Randy J Chandler; Mark S Sands; Charles P Venditti
Journal:  Hum Gene Ther       Date:  2017-04       Impact factor: 5.695

Review 2.  Direct Cardiac Cellular Reprogramming for Cardiac Regeneration.

Authors:  Vivekkumar Patel; Megumi Mathison; Vivek P Singh; Jianchang Yang; Todd K Rosengart
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-09

3.  Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.

Authors:  Sven T Pleger; Changguang Shan; Jan Ksienzyk; Raffi Bekeredjian; Peter Boekstegers; Rabea Hinkel; Stefanie Schinkel; Barbara Leuchs; Jochen Ludwig; Gang Qiu; Christophe Weber; Philip Raake; Walter J Koch; Hugo A Katus; Oliver J Müller; Patrick Most
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

4.  Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue.

Authors:  Sven T Pleger; Patrick Most; Matthieu Boucher; Stephen Soltys; J Kurt Chuprun; Wiebke Pleger; Erhe Gao; Abhijit Dasgupta; Giuseppe Rengo; Andrew Remppis; Hugo A Katus; Andrea D Eckhart; Joseph E Rabinowitz; Walter J Koch
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

Review 5.  Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review.

Authors:  Egidio Imbalzano; Giuseppe Mandraffino; Marco Casciaro; Sebastiano Quartuccio; Antonino Saitta; Sebastiano Gangemi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

6.  Effects of genetic transfection on calcium cycling pathways mediated by double-stranded adeno-associated virus in postinfarction remodeling.

Authors:  Michael G Katz; Sarah M Gubara; Yoav Hadas; Thomas Weber; Arvind Kumar; Efrat Eliyahu; Charles R Bridges; Anthony S Fargnoli
Journal:  J Thorac Cardiovasc Surg       Date:  2019-09-30       Impact factor: 5.209

7.  Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes.

Authors:  Melanie Boerries; Patrick Most; Jonathan R Gledhill; John E Walker; Hugo A Katus; Walter J Koch; Ueli Aebi; Cora-Ann Schoenenberger
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

8.  Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction.

Authors:  A S Fargnoli; M G Katz; R D Williams; A P Kendle; N Steuerwald; C R Bridges
Journal:  Gene Ther       Date:  2015-10-13       Impact factor: 5.250

Review 9.  Calcium Buffering in the Heart in Health and Disease.

Authors:  Godfrey L Smith; David A Eisner
Journal:  Circulation       Date:  2019-05-14       Impact factor: 29.690

10.  S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4.

Authors:  David Rohde; Christoph Schön; Melanie Boerries; Ieva Didrihsone; Julia Ritterhoff; Katharina F Kubatzky; Mirko Völkers; Nicole Herzog; Mona Mähler; James N Tsoporis; Thomas G Parker; Björn Linke; Evangelos Giannitsis; Erhe Gao; Karsten Peppel; Hugo A Katus; Patrick Most
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.